Alcoholic hepatitis is a severe liver condition caused by long-term heavy alcohol use, leading to inflammation and potential liver failure. Symptoms include jaundice, nausea, abdominal pain, fatigue, ...

Alcohol-induced hepatitis is liver damage caused by over-consuming alcohol. It can progress to severe liver scarring called cirrhosis if you continue alcohol use. Alcohol-induced hepatitis, formally ...

Doctors use a combination of methods to diagnose people with alcoholic hepatitis. They may identify the condition according to a person’s medical history, a physical exam, imaging scans, and more.

Please provide your email address to receive an email when new articles are posted on . Small intestinal bacterial overgrowth was present in 25% of patients with severe alcoholic hepatitis vs. 3.3% of ...

Larsucosterol 30 mg and 90 mg reduced 90-day mortality by 41% and 35%, respectively, vs. placebo in the global population. In the U.S. population, larsucosterol reduced 90-day mortality by 57% and 58% ...

Adding fecal microbiota therapy to standard care for steroid-ineligible severe alcoholic-associated hepatitis appeared safe and effective in a small randomized trial from India. Survival at 90 days ...

Alcoholic cirrhosis is the severe, final stage of alcohol-associated liver disease, resulting from long-term heavy alcohol consumption. The disease involves permanent scarring of the liver, which ...

Severe alcohol-associated hepatitis (sAH) remains a highly lethal condition with limited therapeutic options. Characterized by rapid liver decompensation, sAH is often accompanied by acute kidney ...

Hepatitis is an inflammation of the liver. It’s considered acute until it lasts six months, at which point it’s considered chronic. Complications that can develop from chronic hepatitis include a ...

Pentoxifylline, an anti–tumor necrosis factor alpha agent, did not improve survival outcomes in patients with severe alcohol-associated hepatitis complicated by acute kidney injury (AKI). Severe ...

First-in-human data shared at The Liver Meeting® 2022 supported a favorable safety and tolerability profile for INT-787 in healthy adults Company announces severe alcohol-associated hepatitis (sAH), a ...